Trevi Therapeutics's total assets for Q1 2025 were $107.00M, a decrease of -3.51% from the previous quarter. TRVI total liabilities were $7.55M for the fiscal quarter, a -32.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.